search
Back to results

Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients (EGéSOR)

Primary Purpose

Head and Neck Squamous Cell Carcinomas (HNSCCs)

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
CGA and geriatric follow-up
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Head and Neck Squamous Cell Carcinomas (HNSCCs) focused on measuring head and neck squamous cell carcinomas (HNSCCs), elderly, cancer, comprehensive geriatric assessment, functional status, malnutrition, survival

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients aged 65 years old and over (modified by amendment n 2 -1/07/2014)
  • macroscopical lesions suggesting an cancerous tumor in head and neck awaiting pathology confirmation;
  • support in one of ENT/Maxilla-facial surgery departments in the study;
  • patients insured by a social security;
  • patients informed of the study, and having given his non opposition verbally.

Exclusion Criteria:

  • patients deprived of liberty or under legal protection;
  • presence of psychological, family, socials or geographic condition(s) that may interfere with the proper conduct of the study;
  • personal history of head and neck cancer except single surgery for squamos cell carcinoma without additional treatment (without curietherapy or RT) with a free interval of at least 5 years (modified by amendment n 2 -1/07/2014)
  • patients with cancerous tumor of sinus and salivary glands

Sites / Locations

  • Centre Hospitalier Intercommunal de Créteil / Hopital Henri Mondor

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Comprehensive Geriatric Assessment

Arm Description

In the control arm, patients are followed-up by the head-and-neck physician, oncologist and radiotherapists and did not benefit of Comprehensive Geriatric Assessment.

The CGA (Comprehensive Geriatric Assessment) is a multidimensional assessment of general health status, using validated scales. It produces an inventory of problems which can then serve to develop an individualized geriatric intervention plan of care and follow-up.

Outcomes

Primary Outcome Measures

Composite criteria, including: death; autonomy (if loss of two points or more in the Activity of Daily Living (ADL) compared with the initial ADL); nutritional status (if weight loss of 10% or more compared to the initial weight at diagnosis

Secondary Outcome Measures

progression-free survival
death
total duration of hospitalization
quality of life (QLQC30, HN35)
costs of treatment

Full Information

First Posted
November 21, 2013
Last Updated
November 19, 2020
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
National Cancer Institute (NCI), Cancéropole Ile De France
search

1. Study Identification

Unique Protocol Identification Number
NCT02025062
Brief Title
Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients
Acronym
EGéSOR
Official Title
Impact of Comprehensive Geriatric Assessment on Malnutrition, Functional Status and Survival in Elderly Patients With Head and Neck Squamous Cell Carcinomas (HNSCCs): a Randomized Controlled Multicenter Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
September 2013 (Actual)
Primary Completion Date
April 2018 (Actual)
Study Completion Date
September 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
National Cancer Institute (NCI), Cancéropole Ile De France

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The intervention tested in this research project aims to reduce this inequality by improving the management of elderly head and neck cancer patients with a specific management. Indeed, the treatment of elderly head and neck cancer patients has specificities concerning treatment options, their tolerance, psychological management, nutritional and functional status, and support needed at home. To assess the overall needs of the elderly patients, an assessment known as "comprehensive geriatric assessment" (CGA) can be performed by a geriatrician with extensive testing and questionnaires. This assessment is long and requires an experienced geriatrician. It leads to the development of an individualized treatment plan (physiotherapy, psychological follow-up, support at home, nutritional management ...) and follow-up to adapt the necessary cares for the duration of the cancer treatment. The CGA utility has been studied in elderly patients with nonmalignant diseases. Studies have shown that CGA allowed improving survival and maintaining the elderly at home.
Detailed Description
Context: The survival of elderly patients with head and neck squamous cell carcinomas (HNSCC) cancer is greatly reduced compared to younger subjects. Several explanations have been proposed : a competitive comorbidity, a more frequent refusal of standard therapy or the choice of a suboptimal treatment due to fear of toxicities. The comprehensive geriatric assessment (CGA) may influence the decision-making process and help for managing elderly patients with head and neck cancer. The CGA is a multidimensional assessment of general health status, using validated scales. It produces an inventory of problems which can then serve to develop an individualized geriatric intervention plan of care and follow-up. Hypotheses: We postulate that the CGA and the geriatric follow-up improves 1) the therapeutic decision-making process thanks to a better assessment of the patient's functional reserve and its capacity to support or not the treatment, and 2) the overall survival, the functional status and the nutritional status of elderly patients with HNSCC because of a more appropriate treatment and a personalized medical follow-up after surgery and/or radiotherapy and/or chemotherapy or more rarely targeted therapy, with adjustment of treatments and management of comorbidities and/or treatment complications. Main objective: To assess the impact of the CGA and the geriatric follow-up on the overall survival, the functional status and the nutritional status of elderly patients with HNSCC. Secondary objectives: To assess the impact of the CGA on the therapeutic decision, the toxicity and/or complications of treatment, the complete realization of treatment, the autonomy, the institutionalization, the total hospitalization stay, the quality of life of elderly patients with HNSCCs and the costs.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head and Neck Squamous Cell Carcinomas (HNSCCs)
Keywords
head and neck squamous cell carcinomas (HNSCCs), elderly, cancer, comprehensive geriatric assessment, functional status, malnutrition, survival

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
499 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
In the control arm, patients are followed-up by the head-and-neck physician, oncologist and radiotherapists and did not benefit of Comprehensive Geriatric Assessment.
Arm Title
Comprehensive Geriatric Assessment
Arm Type
Experimental
Arm Description
The CGA (Comprehensive Geriatric Assessment) is a multidimensional assessment of general health status, using validated scales. It produces an inventory of problems which can then serve to develop an individualized geriatric intervention plan of care and follow-up.
Intervention Type
Other
Intervention Name(s)
CGA and geriatric follow-up
Intervention Description
The CGA is a multidimensional assessment of general health status, using validated scales. It produces an inventory of problems which can then serve to develop an individualized geriatric intervention plan of care and follow-up
Primary Outcome Measure Information:
Title
Composite criteria, including: death; autonomy (if loss of two points or more in the Activity of Daily Living (ADL) compared with the initial ADL); nutritional status (if weight loss of 10% or more compared to the initial weight at diagnosis
Time Frame
6 months after the randomization
Secondary Outcome Measure Information:
Title
progression-free survival
Time Frame
6 month, 12 month and 24 month after the randomization
Title
death
Time Frame
6 month , 12 month and 24 month after the randomization
Title
total duration of hospitalization
Time Frame
6 month, 12 month and 24 month after the randomization
Title
quality of life (QLQC30, HN35)
Time Frame
6 month , 12 month and 24 month after the randomization
Title
costs of treatment
Time Frame
6 month , 12 month and 24 month after the randomization

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients aged 65 years old and over (modified by amendment n 2 -1/07/2014) macroscopical lesions suggesting an cancerous tumor in head and neck awaiting pathology confirmation; support in one of ENT/Maxilla-facial surgery departments in the study; patients insured by a social security; patients informed of the study, and having given his non opposition verbally. Exclusion Criteria: patients deprived of liberty or under legal protection; presence of psychological, family, socials or geographic condition(s) that may interfere with the proper conduct of the study; personal history of head and neck cancer except single surgery for squamos cell carcinoma without additional treatment (without curietherapy or RT) with a free interval of at least 5 years (modified by amendment n 2 -1/07/2014) patients with cancerous tumor of sinus and salivary glands
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eléna Paillaud, MD / PhD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lydia Brugel, MD / PhD
Organizational Affiliation
Centre Hospitalier Intercommunal de Créteil
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Intercommunal de Créteil / Hopital Henri Mondor
City
Créteil
ZIP/Postal Code
94000
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
17558509
Citation
Abstracts of the 6th European Congress of Oto-Rhino-Laryngology Head and Neck Surgery, June 30-July 4, 2007, Vienna, Austria. Eur Arch Otorhinolaryngol. 2007 Jun;264 Suppl 1:S1-354. doi: 10.1007/s00405-007-0343-8. No abstract available.
Results Reference
background
PubMed Identifier
19536763
Citation
Homma A, Sakashita T, Oridate N, Suzuki F, Suzuki S, Hatakeyama H, Mizumachi T, Taki S, Fukuda S. Importance of comorbidity in hypopharyngeal cancer. Head Neck. 2010 Feb;32(2):148-53. doi: 10.1002/hed.21158.
Results Reference
background
PubMed Identifier
24923533
Citation
Brugel L, Laurent M, Caillet P, Radenne A, Durand-Zaleski I, Martin M, Baron M, de Kermadec H, Bastuji-Garin S, Canoui-Poitrine F, Paillaud E. Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR). BMC Cancer. 2014 Jun 13;14:427. doi: 10.1186/1471-2407-14-427.
Results Reference
derived

Learn more about this trial

Comprehensive Geriatric Assessment and Head and Neck Elderly Cancer Patients

We'll reach out to this number within 24 hrs